Emily Kaiser Maharjan

A review of studies, presentations and discussions at ASRS 2021 in San Antonio, Texas.

Paul Hallen discusses the Retina Industry Insights panel at the Ophthalmology Innovation Summit in San Antonio, Texas.

The EIDON Ultra-Widefield Lens module from iCare USA has received 510(k) approval from the FDA for distribution in the US.

The white cane receives assistive updates to guide visually impaired users to destinations, making indoor navigation in unfamiliar locations easier and safer.

A post-conference guide for ophthalmologists after the conclusion of EURETINA 2021.

OCULUS has combined efforts with International Myopia Institute to raise awareness of myopia and drive scientific advancements to prevent sight-threatening complications and blindness, which may arise as a result.

The U.S. FDA granted orphan drug designation to ADX-2191, methotrexate for intravitreal injection, as treatment for retinitis pigmentosa.

If approved, Genentech’s treatment of faricimab will be the first and only medicine targeting two distinct pathways, Ang-2 and VEGF-A, that often cause retinal diseases that may cause vision loss.

The glaucoma treatment company rebrands to align more closely with goals and direction of the company.

A new MRCS ophthalmology examination will be offered to ICO College Members beginning in 2022.